CLL and COVID-19 at the Hospital Clinic of Barcelona: an interim report

MeSH terms

• Adenine / analogs & derivatives
• Age Factors
• Aged
• Aged, 80 and over
• Antineoplastic Agents / therapeutic use
• Antiviral Agents / therapeutic use
• Betacoronavirus / pathogenicity*
• Biomarkers / blood
• COVID-19
• Coronavirus Infections / complications
• Coronavirus Infections / drug therapy
• Coronavirus Infections / epidemiology*
• Coronavirus Infections / virology
• Disease Progression
• Female
• Ferritins / metabolism
• Fibrin Fibrinogen Degradation Products / metabolism
• Humans
• Hydroxychloroquine / therapeutic use
• Leukemia, Lymphocytic, Chronic, B-Cell / complications
• Leukemia, Lymphocytic, Chronic, B-Cell / drug therapy
• Leukemia, Lymphocytic, Chronic, B-Cell / epidemiology*
• Lymphopenia / complications
• Lymphopenia / drug therapy
• Lymphopenia / epidemiology*
• Male
• Middle Aged
• Pandemics*
• Piperidines
• Pneumonia, Viral / complications
• Pneumonia, Viral / drug therapy
• Pneumonia, Viral / epidemiology*
• Pneumonia, Viral / virology
• Prevalence
• Protein Kinase Inhibitors / therapeutic use
• Pyrazoles / therapeutic use
• Pyrimidines / therapeutic use
• SARS-CoV-2
• Spain / epidemiology
• Survival Analysis